During the past decade, Grene Vision Group conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 1 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 1 clinical trials were completed. i.e. 33.3% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Grene Vision Group" are "Glaucoma, Open-Angle" (3 trials), "Blepharitis" (1 trials), "Corneal Ectasia" (1 trials) and "Keratoconus" (1 trials). Many other conditions were trialed in "Grene Vision Group" in a lesser frequency.

Most popular intervention types in "Grene Vision Group" are "Device" (4 trials) and "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "OMNI® Surgical System" (3 trials), "Azithromycin ophthalmic solution, 1%" (1 trials), "KXL System (15 mW/cm2)" (1 trials), "KXL System (30 mW/cm2)" (1 trials) and "KXL System (45 mW/cm2)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Grene Vision Group" are 5 trials for "All" genders.

Currently, there are NaN active trials in "Grene Vision Group". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Grene Vision Group, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Grene Vision Group, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".